Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Actavis plc announces agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to divest Actavis Foshan, China


Friday, 24 Jan 2014 04:05pm EST 

Actavis plc:Says that it has signed and completed an agreement for Zhejiang Chiral Medicine Chemicals Co., Ltd to acquire Actavis' interest in Actavis (Foshan) Pharmaceuticals Co., Ltd., an Actavis subsidiary based in Foshan, China.Says it intends to continue further commercial operations in China in collaboration with its preferred business partners. 

Company Quote

215.55
0.7 +0.33%
30 Jul 2014